Bayanin Blogs
Ra'ayoyi: 4732 Mawallafi: Yourxc Lokacin Bugawa: 2026-11-05 Asalin: Shafin
Nemo mafi kyawun alluran fatar fata kuma yawanci zaku haɗu da sunaye guda uku iri ɗaya: glutathione, bitamin C (ascorbic acid) da tranexamic acid (TXA). Asibitoci sukan gabatar da su a matsayin masu musanyawa 'harbin haske', duk da haka suna aiki ta hanyoyi daban-daban, ana isar da su ta hanyoyi daban-daban kuma suna ɗaukar matakan shaida daban-daban. To wanne ne ya fi haskaka fata? Amsar gaskiya ta dogara da matsalar launin launi da ake yi.
A cikin wannan labarin, ''brightening'' na nufin sautin maraice da shuɗewar pigment mai yawa kamar melasma, tabon rana ko alamun kumburi. Ba yana nufin canza yanayin halittar mutum, launin fata da aka ƙaddara ba, kuma babu ɗayan waɗannan sinadaran da zai iya yin hakan har abada. A ƙasa zaku sami tebur kwatancen gefe-gefe, ɗan gajeren bayanin kowane sashi, jagorar yanke shawara ta hanyar damuwa da fata da mahimman abubuwan aminci da ka'idoji waɗanda asibitoci da masu rarraba yakamata su sani.
Factor |
Glutathione (GSH) |
Vitamin C (ascorbic acid) |
Tranexamic acid (TXA) |
|---|---|---|---|
Babban tsari |
Antioxidant tripeptide; yana hana tyrosinase kai tsaye da kai tsaye kuma yana canza samar da melanin daga eumelanin duhu zuwa phaeomelanin mai haske. |
Antioxidant; yana hana tyrosinase ta hanyar yin hulɗa da jan karfe a wurin aiki na enzyme, yana rage samuwar melanin |
Plasmin mai hanawa; yana katse hanyar plasminogen-plasmin wanda ke danganta bayyanar UV da ƙwayoyin fata zuwa haɓakar melanocyte. |
Yadda ake amfani da shi |
Na baka capsules ko lozenges, Topical creams; IV drips shahararru ne amma ba-lakabi; wani lokacin ana ƙara zuwa intradermal mesotherapy cocktails |
Maganin magani; intradermal mesotherapy ko microneedling don pigment; babban kashi IV infusions ne daban, tsarin amfani |
Intradermal microinjection ko mesotherapy a cikin rauni, microneedling, Topical, da na baka (rubutun magani) |
Mafi dacewa da |
Gabaɗaya dullness da tallafin antioxidant, azaman ƙari |
Dullness, hoto-lalata da m epidermal pigment; abokin tarayya na gama gari zuwa TXA |
Melasma da taurin kai, hormone- ko UV-kore launin fuskar fuska |
Ingancin shaida |
Ƙananan RCTs na baka da na waje suna nuna matsakaicin ragi na melanin-index; Ɗaya daga cikin raunin nazarin IV mai sarrafa placebo, wanda ba shi da mahimmanci |
Ƙananan gwaje-gwaje da nazarin meta-bincike na 2024 yana nuna mesotherapy tare da bitamin C yana yin daidai da TXA mesotherapy a cikin melasma. |
Mafi ƙarfi daga cikin uku don melasma, kodayake yawancin binciken allura har yanzu ƙanana ne da gajere |
Maɓallin aminci bayanin kula |
Amfani da IV da ke da alaƙa da hanta, koda da halayen fata a cikin gargaɗin mai sarrafawa; babu yarda da maganin IV don walƙiya fata |
Yin amfani da intradermal na iya yin rauni ko ƙonewa; Amfani mai girma na IV yana ɗaukar dutsen koda da damuwa-rashin G6PD |
Jajayen gida, rauni da rashin jin daɗi; nunawa don haɗarin clotting shine daidaitaccen aiki kafin amfani da tsarin |
Haɗuwa na yau da kullun |
Ƙara zuwa TXA + bitamin C cocktails |
Haɗe tare da TXA, tare da ko ba tare da glutathione ba |
Gishiri mai tushe na mafi yawan melasma cocktails |
Glutathione antioxidant ne na halitta da ake samu a cikin kusan kowane tantanin halitta. Reviews bayyana tasirin ta walƙiya kamar yadda ya zo daga kai tsaye da kuma kai tsaye hanawa na tyrosinase kuma daga canza melanin kira zuwa haske pigment (Sonthalia et al., 2016). A cikin binciken da aka sarrafa, duk da haka, tasirin yana da matsakaici. Wani gwaji da aka yi bazuwar, makafi biyu a cikin masu aikin sa kai na Thai 60 sun gano cewa 500 MG na glutathione na baka kowace rana tsawon makonni hudu yana rage ma'aunin melanin fiye da placebo a wurare biyu kawai cikin shida (Arjinpathana da Asawanonda). Binciken buɗaɗɗen lakabi na buccal lozenge a cikin matan Filipino 30 kuma sun ba da rahoton faɗuwar alamar melanin, amma ba ta da rukunin placebo (Handog et al., 2016).
Shaidar glutathione na cikin jijiya ta fi rauni har yanzu. Binciken IV mai sarrafa placebo kawai bai sami wani babban bambanci daga saline (37.5% vs 18.7% inganta, p = 0.054), haɓakawa ya ɓace a cikin watanni shida, kuma mahalarta da yawa sun sami gwajin hanta mara kyau ko anaphylaxis (Zubair et al., 2016). Wani bita na tsari na 2024 ya kammala cewa IV glutathione an hana shi don walƙiya fata kuma glutathione 'na iya aiki fiye da matsayin antioxidant a cikin melasma' (Sarkar et al.). Don bayanan abokan haƙuri, duba mu jagora ga yadda glutathione fatar fata allura ke aiki.
Ascorbic acid yana kawar da radicals kyauta da hasken UV ya haifar kuma yana hana tyrosinase, wanda shine dalilin da ya sa an dade ana amfani da shi don tsufa na hoto da hyperpigmentation (Telang, 2013). Babban rauninsa shine bayarwa: bitamin C ba shi da kwanciyar hankali kuma yana da wuya a shiga cikin dermis a cikin ƙididdiga masu amfani, wanda ya bayyana sha'awar mesotherapy da microneedling.
Lokacin da aka yi wa bitamin C allurar a cikin fata don melasma, yana riƙe da kansa. Binciken meta-bincike na 2024 na binciken biyar (masu haƙuri 127) ba su sami wani bambanci mai mahimmanci a cikin ci gaban MASI tsakanin TXA mesotherapy da bitamin C mesotherapy kuma an yanke hukunci duka biyun suna da aminci (Liao et al.). Karatuttukan sun kasance ƙanana, don haka an fi karanta wannan a matsayin 'mai kwatankwacin iyakacin bayanai' maimakon shaidar daidaito.
Tranexamic acid an samar dashi azaman magani don rage zubar jini. Matsayinsa a cikin launi ya fito ne daga toshe ayyukan plasmin, hanyar da ke cikin kunna melanocyte ta UV. A cikin binciken farko na intradermal, matan Koriya 85 sun karbi 4 mg / mL microinjections mako-mako a cikin raunuka na melasma na makonni 12; Ma'anar MASI ya faɗi daga 13.22 zuwa 7.57 tare da ƙananan sakamako masu illa (Lee et al., 2006). Wannan binciken ba shi da ƙungiyar sarrafawa. Wani gwaji da aka bazu daga baya a cikin marasa lafiya 60 ya sami 35.72% MASI ingantawa tare da microinjections TXA da 44.41% tare da TXA da aka kawo ta microneedling, ba tare da wani babban haɗari ba (Budamakuntla et al., 2013).
Cikakkun bayanai na yarjejeniya, tazarar zama da zaɓin haƙuri an rufe su a cikin labarin sadaukarwar mu akan tranexamic acid mesotherapy don melasma , don haka ba za mu maimaita su a nan ba.
Babu allurar farar fata guda ɗaya. Zaɓin da ya dace yana bin ganewar asali:
TXA shine sinadari na farko da yawancin masu ilimin fata ke kaiwa ga, isar da su ta cikin gida ko tare da microneedling, tare da tsayayyen kariya ta rana. Vitamin C mesotherapy shine madaidaicin madadin ko abokin tarayya, idan aka ba da kwatankwacin sakamako a cikin meta-bincike. Glutathione ƙari ne na zaɓin zaɓi, ba amsa ce kaɗai ba.
Don gajiye, sallow ko lalata fata ba tare da ƙayyadadden cuta mai launi ba, tallafin antioxidant ya fi dacewa. Vitamin C shine tushen ma'ana, kuma glutathione na iya ba da gudummawar fa'idar antioxidant. Ya kamata a tsara abubuwan da ake tsammani a matsayin 'saboda fata, ko da fata', ba launin fata ba.
Alamun da aka bari bayan kuraje ko hantsi yawanci suna shuɗe tare da lokaci, kariya ta rana da kulawa mai laushi. Idan aka yi amfani da alluran allura, ƙananan ƙa'idodin fushi tare da bitamin C ko TXA suna da ma'ana, saboda mummunan magani na iya haifar da sabon launi. Mu bayyani na alluran da ke haskaka fata don haɓakar pigmentation yana bayyana manyan nau'ikan launi dalla-dalla.
Vitamin C da glutathione galibi ana zabar su azaman sinadarai masu tallafi a kusa da lasers ko kwasfa. Ba sa maye gurbin takamaiman tsarin jiyya na launi.
Saboda sinadaran guda uku suna aiki akan matakai daban-daban na samuwar pigment, ƙirar zamani masu haskakawa sukan haɗa TXA, bitamin C da glutathione maimakon zaɓar ɗaya. Bayanan asibiti suna goyan bayan wannan tunani, aƙalla a cikin ƙananan gwaji. A cikin makafi guda biyu, gwajin fuska na 24 melasma marasa lafiya, TXA da ascorbic acid sun saukar da MASI maki fiye da TXA da placebo a makonni 8 da 12, kodayake zafi mai zafi ya fi sananne a gefen haɗin gwiwa (Pazyar et al., 2022). A cikin wani gwajin-fuska na marasa lafiya 30, hadaddiyar giyar TXA 4 mg/mL, bitamin C 3% da glutathione 2% sun rage mMASI fiye da TXA da bitamin C kadai, tare da irin wannan adadin ja, kumburi da rauni (Iraji et al., 2019).
Don ƙarin gabatarwa ga yadda waɗannan samfuran suke matsayi, karanta mu jagora ga alluran farar fata da haskaka fata.
IV glutathione ba maganin da aka yarda da fata ba ne a kasuwanni da yawa. A cikin shawarwarinta na 2019, FDA ta Philippine ta ce ba ta amince da kowane samfurin allura don walƙiya fata ba, an yarda da glutathione injectable kawai a matsayin haɗin gwiwa a cikin chemotherapy cisplatin, kuma ta yi gargadin yiwuwar hanta, koda da tasirin tsarin juyayi da cututtukan Stevens-Johnson.
Babban adadin bitamin C na IV yana ɗaukar nasa kasada. Shawarar guda ɗaya ta lura cewa allurar bitamin C na iya haifar da duwatsun koda kuma yawancin allurai sun haifar da hemodialysis a cikin mutanen da ke da rashi G6PD.
Alluran gida ba su da haɗari. Yi tsammanin ja mai ɗan lokaci, tsawa, kumburi ko kumbura. Dabarar bakararre da madaidaicin zurfin suna da mahimmanci.
Sakamako ba na dindindin ba ne. Pigment yana dawowa idan bayyanar UV, hormones ko kumburi ya ci gaba. Kariyar rana ta yau da kullun wani bangare ne na kowace yarjejeniya.
Sani dokokin gida. Rijistar samfur da wanda zai iya yin allura ya bambanta ta ƙasa. Ya kamata a rubuta magani kuma ƙwararrun likitoci su ba su.
Asibitoci suna ganin mafi kyawun sakamako da ƙananan gunaguni lokacin da suka fara gano nau'in alatun, zaɓi ka'idodin tushen TXA don melasma kuma gabatar da glutathione da gaskiya azaman haɗin gwiwar antioxidant maimakon mai canza launin fata. Masu rarrabawa su duba cewa kowane samfurin rajista da lakabin ya dace da kasuwar da suke so.
AOMA yana ƙera mafita na mesotherapy mai haske, gami da TXA, bitamin C da hanyoyin haɗin gwiwa, don samar da haja da OEM. Kuna iya lilo a cikin AOMA kewayon allurar farar fata . MOQ yana farawa daga raka'a 200 don duka hannun jari da oda OEM. Ana jigilar kayayyaki a cikin sa'o'i 24, kuma lokacin jagorar OEM shine makonni 2-3 bayan aikin zane-zane, an tabbatar da dabara da cikakkun bayanan marufi. AOMA yana riƙe da CE, ISO 13485, GMP da takaddun shaida na FDA.
Babu mai nasara daya. Ga melasma, tranexamic acid yana da bayanan allura mafi tallafi. Don rashin jin daɗi na gaba ɗaya, bitamin C shine zaɓin antioxidant mai ma'ana. Glutathione galibi ƙari ne. Dole ne likita ya bincika matsalar pigment kafin zabar.
Ba a fili ba. Dukansu biyu suna da ƙaƙƙarfan shaida, ɗan gajeren lokaci. Vitamin C yana da ƙarin bayanan allura don melasma, yayin da IV glutathione ya kasa doke placebo a cikin gwajin sarrafawa kawai.
Ee, hadaddiyar giyar ta zama ruwan dare gama gari, kuma ƙananan gwaje-gwaje masu tsaga-fuska sun gano cewa ƙara bitamin C, sa'an nan kuma glutathione, zuwa TXA sun inganta ƙimar melasma. Ƙonawa ko ƙura na iya karuwa tare da haɗuwa.
A'a. Suna iya yin shuɗewar launin launi mai yawa har ma da sautin sauti, amma ba sa canza launin fata na halitta, kuma sakamakon yana dushewa ba tare da kariya ta rana da kiyayewa ba.
Masu gudanarwa irin su Philippine FDA sun yi gargadi game da shi, kuma 2024 nazari na yau da kullum da aka yi la'akari da IV glutathione an hana shi don walƙiya fata saboda rashin inganci da sakamako masu illa.
Lee JH, Park JG, Lim SH, et al. Microinjection intradermal microinjection na tranexamic acid don maganin ciwon huhu a cikin majinyatan Asiya: gwajin asibiti na farko. Dermatol Surg . 2006;32 (5):626–631. Saukewa: 16706756.
Budamakuntla L, Loganathan E, Suresh DH, et al. Bazuwar, lakabin buɗaɗɗe, kwatankwacin nazarin microinjections na tranexamic acid da tranexamic acid tare da microneedling a cikin marasa lafiya tare da melasma. J Cutan Aesthet Surg . 2013; 6 (3): 139–143. Saukewa: 24163529.
Liao X, Cheng F, Jiang Y. Inganci da aminci na mesotherapy tare da tranexamic acid tare da bitamin C a cikin maganin melasma: nazarin meta da bita na tsari. J Cosmet Dermatol . 2024;23 (9):2785–2792. Saukewa: 38693699.
Pazyar N, Molavi SN, Hosseinpour P, et al. Ingancin allurar intradermal na tranexamic acid da ascorbic acid tare da tranexamic acid da placebo a cikin jiyya na melasma: gwajin kwatankwacin fuska. Lafiya Sci Rep . 2022; 5 (2): e537. Saukewa: 35284654.
Iraji F, Nasimi M, Asilian A, et al. Ingancin mesotherapy tare da tranexamic acid da ascorbic acid tare da kuma ba tare da glutathione ba a cikin jiyya na melasma: gwaji na kwatanta fuska. J Cosmet Dermatol . 2019;18 (5): 1416–1421. Saukewa: 30735611.
Sonthalia S. Daulatabad D Indiya J Dermatol Venereol Leprol . 2016;82 (3):262–272. Saukewa: 27088927.
Sarkar R, Yadav V, Yadav T, et al. Glutathione azaman wakili mai walƙiya fata kuma a cikin melasma: nazari na yau da kullun. Int J Dermatol . 2025; 64 (6): 992-1004 (kan layi 2024). Saukewa: 3944151.
Arjinpathana N, Asawanonda P. Glutathione a matsayin wakili mai launin fata: bazuwar, makafi biyu, nazarin sarrafa wuribo. J Dermatolog Jiyya . 2012;23 (2):97–102. Saukewa: 20524875.
Handog EB, Datuin MS, Singzon IA. Budaddiyar lakabin, gwajin hannu-ɗaya na aminci da ingancin sabon shiri na glutathione azaman wakili mai haskaka fata a cikin matan Filipino. Int J Dermatol . 2016;55 (2):153–157. Saukewa: 26148180.
Zubair S, Hafeez S, Mujtaba G. Tasirin glutathione na ciki vs. placebo don haskaka sautin fata. J Pak Assoc Dermatol . 2016;26(3):177. https://jpad.com.pk/index.php/jpad/article/view/18
Farashin PS. Vitamin C a cikin dermatology. Indiya Dermatol Online J. 2013; 4 (2): 143–146. Saukewa: 23741676.
Cibiyar Abinci da Magunguna ta Philippines. Shawarar FDA No. 2019-182: Rashin aminci amfani da glutathione azaman wakili na walƙiya fata. 2019. https://www.fda.gov.ph/fda-advisory-no-2019-182-unsafe-use-of-glutathione-as-skin-lightening-agent/
Wannan labarin don dalilai ne na ilimi kawai kuma ba shawarar likita ba ne. ƙwararrun likitoci ya kamata a tantance su kuma yi su bisa ga ƙa'idodin gida.
Haɗu da AOMA
Laboratory
Kashi na samfur